Next Century Growth Investors LLC decreased its stake in Bowhead Specialty Holdings Inc. (NYSE:BOW - Free Report) by 30.9% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 157,977 shares of the company's stock after selling 70,568 shares during the quarter. Next Century Growth Investors LLC owned approximately 0.48% of Bowhead Specialty worth $5,611,000 as of its most recent SEC filing.
A number of other hedge funds and other institutional investors have also made changes to their positions in BOW. New York State Common Retirement Fund acquired a new position in Bowhead Specialty in the 4th quarter valued at about $64,000. US Bancorp DE purchased a new position in shares of Bowhead Specialty in the 4th quarter valued at $76,000. KLP Kapitalforvaltning AS purchased a new stake in Bowhead Specialty in the fourth quarter valued at $107,000. Pictet Asset Management Holding SA acquired a new stake in shares of Bowhead Specialty during the fourth quarter worth about $145,000. Finally, Corebridge Financial Inc. lifted its stake in Bowhead Specialty by 49.9% in the fourth quarter. Corebridge Financial Inc. now owns 5,787 shares of the company's stock valued at $206,000 after buying an additional 1,926 shares during the last quarter.
Analyst Upgrades and Downgrades
BOW has been the topic of a number of research reports. Piper Sandler started coverage on Bowhead Specialty in a report on Wednesday. They set an "overweight" rating and a $44.00 price target on the stock. JPMorgan Chase & Co. lifted their price target on Bowhead Specialty from $30.00 to $35.00 and gave the company a "neutral" rating in a research note on Tuesday, April 8th. JMP Securities increased their price target on shares of Bowhead Specialty from $38.00 to $40.00 and gave the company a "market outperform" rating in a report on Friday, April 11th. Finally, Keefe, Bruyette & Woods reduced their price target on shares of Bowhead Specialty from $44.00 to $43.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. Two research analysts have rated the stock with a hold rating and four have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average price target of $37.17.
Get Our Latest Stock Report on BOW
Bowhead Specialty Trading Up 1.2 %
Shares of Bowhead Specialty stock traded up $0.47 during trading on Thursday, hitting $40.30. 90,025 shares of the company were exchanged, compared to its average volume of 212,368. The firm has a 50 day moving average price of $36.14 and a 200 day moving average price of $33.94. Bowhead Specialty Holdings Inc. has a fifty-two week low of $22.14 and a fifty-two week high of $42.29.
Bowhead Specialty (NYSE:BOW - Get Free Report) last posted its quarterly earnings data on Tuesday, February 25th. The company reported $0.42 EPS for the quarter, beating analysts' consensus estimates of $0.35 by $0.07. The company had revenue of $184.77 million for the quarter, compared to analyst estimates of $102.12 million. Sell-side analysts anticipate that Bowhead Specialty Holdings Inc. will post 1.36 EPS for the current fiscal year.
Insider Activity
In other Bowhead Specialty news, Director Ava Schnidman purchased 1,493 shares of the business's stock in a transaction on Friday, February 28th. The stock was bought at an average cost of $33.41 per share, for a total transaction of $49,881.13. Following the acquisition, the director now owns 1,893 shares of the company's stock, valued at approximately $63,245.13. The trade was a 373.25 % increase in their position. The acquisition was disclosed in a legal filing with the SEC, which is available at this link.
Bowhead Specialty Company Profile
(
Free Report)
Bowhead Specialty Holdings Inc provides specialty property and casualty insurance products in the United States. It underwrites casualty insurance solutions for risks in the construction, distribution, heavy manufacturing, real estate, and hospitality segments; professional liability insurance solutions for financial institutions, private and public directors and officers liability insurance, errors and omissions liability insurance, and cyber segments; and healthcare solutions for hospitals, senior care providers, managed care organizations, miscellaneous medical facilities, and healthcare management liability segments.
Further Reading

Before you consider Bowhead Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bowhead Specialty wasn't on the list.
While Bowhead Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.